Medicine & Life Sciences
sacituzumab govitecan
100%
Immunoconjugates
81%
Neoplasms
73%
Mutation
72%
Ovarian Neoplasms
68%
Carcinoma
63%
Heterografts
53%
Trophoblasts
44%
Genes
43%
Endometrial Neoplasms
43%
Ovarian Epithelial Carcinoma
43%
In Vitro Techniques
42%
Cell Line
42%
Vascular Endothelial Growth Factor Receptor-2
40%
Carcinosarcoma
39%
Drug Delivery Systems
39%
Duocarmycins
38%
Monozygotic Twins
35%
Surface Antigens
34%
Drug Therapy
32%
Uterine Cervical Neoplasms
29%
Whole Exome Sequencing
28%
Osteopetrosis
27%
Semaphorins
27%
pembrolizumab
27%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
27%
X-Linked Genes
24%
Biliary Liver Cirrhosis
23%
Macrophage Activation
22%
Macrophages
22%
Irinotecan
22%
Methylation
21%
Integrins
21%
Growth
21%
Afatinib
20%
Vascular Endothelial Growth Factor Receptor
20%
Morphogenesis
19%
Ado-Trastuzumab Emtansine
19%
Triple Negative Breast Neoplasms
18%
MEK162
18%
Proteins
18%
Genome
17%
olaparib
17%
Phosphatidylinositol 3-Kinases
17%
pertuzumab
16%
Autosomal Dominant Familial Periodic Fever
16%
Neoplasm Metastasis
16%
Folate Receptor 1
16%
Non-Receptor Type 11 Protein Tyrosine Phosphatase
15%
Tumor Cell Line
15%